Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
BTK Monoclonal Antibody (OTI3D11), TrueMAB™, OriGene

Mouse Monoclonal Antibody
Supplier: OriGene TA501092S


Description
BTK Monoclonal antibody specifically detects BTK in Human samples. It is validated for Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western BlotSpecifications
BTK | |
Monoclonal | |
0.5 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
Q06187 | |
Mouse | |
Affinity chromatography | |
RUO | |
695 | |
-20° C, Avoid Freeze/Thaw Cycles | |
IgG3 |
Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot | |
OTI3D11 | |
Unconjugated | |
BTK | |
agammaglobulinaemia tyrosine kinase; agammaglobulinemia tyrosine kinase; AGMX1; AI528679; AT; ATK; B-cell progenitor kinase; BPK; Bruton agammaglobulinemia tyrosine kinase; Bruton tyrosine kinase; Bruton's tyrosine kinase; BTK; dominant-negative kinase-deficient Brutons tyrosine kinase; IMD1; Kinase EMB; MGC126261; MGC126262; OTTHUMP00000023677; PSCTK1; RP1-164F3.2; truncated Bruton agammaglobulinemia tyrosine kinase; tyrosine-protein kinase BTK; Tyrosine-protein kinase BTK (Brutons tyrosine kinase) (Agammaglobulinaemia tyrosine kinase) (ATK) (B cell progenitor kinase) (BPK) (Kinase EMB); tyrosine-protein kinase BTK isoform (lacking exon 13 to 17); tyrosine-protein kinase BTK isoform (lacking exon 14); xid; XLA; X-linked immune deficiency | |
Full length human recombinant protein of human BTK produced in HEK293T cell. | |
30 μL | |
Primary | |
Human | |
Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction